nsc 624231 has been researched along with efavirenz in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Andrews , CW; Boone, LR; Chan, JH; Cowan, JR; Creech, KL; Ferris, RG; Hazen, RJ; Hong, JS; Hopkins, A; Hunter , RN; Orr, GF; Ott, RJ; Reitter, BE; Ren, J; Roberts, GB; Sherman, DB; Short, SA; Sparks, SM; St Clair, M; Stammers, DK; Stuart, DI; Weaver, K | 1 |
| Artico, M; De Martino, G; La Colla, P; La Regina, G; Loi, AG; Marceddu, T; Massa, S; Mura, M; Silvestri, R; Vargiu, L | 1 |
2 other study(ies) available for nsc 624231 and efavirenz
| Article | Year |
|---|---|
2-Amino-6-arylsulfonylbenzonitriles as non-nucleoside reverse transcriptase inhibitors of HIV-1.
Topics: Anti-HIV Agents; Binding Sites; Cell Line, Transformed; Crystallography, X-Ray; HIV Reverse Transcriptase; Human T-lymphotropic virus 1; Humans; Models, Molecular; Molecular Conformation; Molecular Structure; Nitriles; Protein Conformation; Structure-Activity Relationship; Sulfones | 2001 |
Novel indolyl aryl sulfones active against HIV-1 carrying NNRTI resistance mutations: synthesis and SAR studies.
Topics: Anti-HIV Agents; Cell Line; Drug Resistance, Viral; HIV-1; Humans; Indoles; Mutation; Reverse Transcriptase Inhibitors; Structure-Activity Relationship; Sulfones | 2003 |